Pharmaceutical
PAREXEL International Corporation , a leading global biopharmaceutical services organization, today announced that the Boards of PAREXEL International and ClinPhone plc, a company traded on the London Stock Exchange, have reached agreement on the terms o
02:03 Jun 13, 2008
According to Narconon Trois-Rivieres, drug addiction is not a random coincidence. The onset of drug addiction may be caused in most instances by a problem, a particular discomfort, an emotional disturbance or physical pain that the individual cannot hand
01:33 Jun 13, 2008
Roche announced today that its new test for detection of Chlamydia trachomatis has received CE Mark certification, allowing it to be sold for clinical use in the European Union. It is designed with a dual target approach to help ensure reliability of tes
01:03 Jun 13, 2008
VION PHARMACEUTICALS, INC. today announced that data from a previously conducted Phase II trial of its lead anticancer agent Cloretazine in elderly patients with acute myelogenous leukemia and high-risk myelodysplastic syndromes had been presented at the
22:33 Jun 12, 2008
New Global Survey Exposes Considerable Burden of Fibromyalgia Including Potential Economic Impact
22:03 Jun 12, 2008
Seven-year rheumatoid arthritis data from open-label extension studies show that treatment with Abbott's HUMIRA resulted in clinical remission among long-standing RA patients when used in combination with methotrexate . The percentage of patients achievi
21:03 Jun 12, 2008
Abbott announced new data from the open-label extension of the ATLAS phase III clinical trial, which showed HUMIRA reduced the signs and symptoms of ankylosing spondylitis for up to three years of treatment among 74 percent of patients tested. AS is a ty
21:03 Jun 12, 2008
New data announced today showed that treating patients with early, active rheumatoid arthritis with Abbott's HUMIRA and methotrexate resulted in an indirect cost savings of euro 4,845 per patient per year compared to MTX treatment alone. These cost savin
21:03 Jun 12, 2008
Amsterdam Molecular Therapeutics , a leader in the field of human gene therapy, announced today that it has concluded enrollment and treated the last patient in the pivotal trial for it's lead product AMT-011 ) for Hyperlipoproteinemia, a seriously debil
20:03 Jun 12, 2008
Seventh grader, Lexi Miletto, whose grandfather, Joseph Miletto died in 2005 of peritoneal mesothelioma, will be a featured speaker at the Gala Dinner on Friday evening, June 27th, part of the Mesothelioma Applied Research Foundation's International Symp
14:53 Jun 12, 2008
Inflazyme Pharmaceuticals Ltd. announced today that it has appointed Mr. Rick Doman as the interim President and CEO effective June 30, 2008. Mr. Doman was formerly President, CEO and Director of Doman Industries Ltd. and Western Forest Products. Mr. Dom
14:04 Jun 12, 2008
Inflazyme Pharmaceuticals Ltd. announced today that it has appointed Mr. Rick Doman as the interim President and CEO effective June 30, 2008. Mr. Doman was formerly President, CEO and Director of Doman Industries Ltd. and Western Forest Products. Mr. Dom
14:01 Jun 12, 2008
Ed Asner, Art Linkletter, Michael Reagan, LAPD Police Chief William Bratton, L.A. Public Health Director Jonathan Fielding, Jack Canfield, Mark Victor Hansen and a host of others join intergenerational experts Debby Bitticks and Dorothy Breininger of Del
13:53 Jun 12, 2008
Bipartisan Package Would Have Improved Benefits for Prevention, Mental Health and Low-Income Programs, Boosted Quality through National E-Prescribing
13:43 Jun 12, 2008
Synovics Pharmaceuticals, Inc., a specialty pharmaceutical company, announced today that on June 6, 2008, it formalized a strategic partnership with Maneesh Pharmaceuticals, LTD through the formation of a joint venture . The JV between the companies is i
13:23 Jun 12, 2008
73655 - 73669 of 82779 Stories
<<
<
Next 15 Pharmaceutical
>
>>
Search News
Daily News
